Literature DB >> 3109377

The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.

L Touqui, A M Shaw, C Dumarey, C Jacquemin, B B Vargaftig.   

Abstract

In the present study we have investigated the effect of changes in the concentration of cytosolic free Ca2+ ([Ca2+]i) on the deacetylation-reacylation of PAF-acether (alkylacetylglycerophosphocholine, alkylacetyl-GPC) by rabbit platelets. Washed platelets were incubated with alkyl[3H]acetyl-GPC ([3H]acetyl-PAF) or [3H]alkylacetyl-GPC ([3H]alkyl-PAF) and [Ca2+]i was subsequently elevated by the addition of the ionophore A23187 or thrombin. The catabolism of PAF-acether was studied by measuring the release of [3H]acetate or the formation of [3H]alkylacyl-GPC. The ionophore inhibited the release of [3H]acetate and the formation of [3H]alkylacyl-GPC with no accumulation of lyso-[3H]PAF, indicating that the deacetylation of PAF-acether was blocked. The effect of ionophore on the deacetylation of PAF-acether was parallel with the increase of [Ca2+]i and could be reversed by the addition of EGTA. In contrast with the prolonged inhibition evoked by ionophore, thrombin, which induced a transient elevation of [Ca2+]i, merely delayed the deacetylation of PAF-acether. Since intact platelets failed to convert exogenous lyso-PAF, the effect of Ca2+ on its acylation was investigated by using platelet homogenates. These experiments showed that the acylation of lyso-PAF was inhibited by the exogenously added Ca2+, with a maximum effect at 1 mM. When the formation of endogenous lyso-PAF from the labelled pool of alkylacyl-GPC was examined, a prolonged increase in the concentration of lyso-PAF with a parallel and equally prolonged decrease in the cellular level of alkylacyl-GPC were observed after the addition of ionophore to intact platelets. The addition of EGTA reversed the effect of ionophore, thus permitting reacylation of lyso-PAF. In contrast, only a transient change in the level of lyso-PAF and alkylacyl-GPC was evoked by the addition of thrombin. Therefore we conclude that the inhibitory effect of Ca2+ on the deacetylation-reacylation of PAF-acether may have an important role in the regulation of its biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109377      PMCID: PMC1147596          DOI: 10.1042/bj2410555

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.

Authors:  M Chignard; J P Le Couedic; B B Vargaftig; J Benveniste
Journal:  Br J Haematol       Date:  1980-11       Impact factor: 6.998

2.  T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

Review 3.  Background and present status of research on platelet-activating factor (PAF-acether).

Authors:  B B Vargaftig; M Chignard; J Benveniste; J Lefort; F Wal
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets.

Authors:  N G Ardlie; M A Packham; J F Mustard
Journal:  Br J Haematol       Date:  1970-07       Impact factor: 6.998

5.  A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

Authors:  M L Blank; T Lee; V Fitzgerald; F Snyder
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

6.  Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages.

Authors:  E Ninio; J M Mencia-Huerta; F Heymans; J Benveniste
Journal:  Biochim Biophys Acta       Date:  1982-01-15

7.  Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases.

Authors:  E E Kröner; B A Peskar; H Fischer; E Ferber
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

8.  Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.

Authors:  H Lachachi; M Plantavid; M F Simon; H Chap; P Braquet; L Douste-Blazy
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

9.  Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.

Authors:  J Benveniste; M Chignard; J P Le Couedic; B B Vargaftig
Journal:  Thromb Res       Date:  1982-03-01       Impact factor: 3.944

10.  Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation.

Authors:  D H Albert; F Snyder
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

View more
  1 in total

1.  Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.

Authors:  I Sobhani; Y Denizot; S Hochlaf; D Rigaud; J Vatier; J Benveniste; M J Lewin; M Mignon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.